151
Views
1
CrossRef citations to date
0
Altmetric
Letters in Response

Comment on “Pediatric guanfacine exposures reported to the National Poison Data System, 2000–2016”

, ORCID Icon, &
Page 767 | Received 29 Sep 2020, Accepted 09 Oct 2020, Published online: 02 Nov 2020

References

  • Winograd EJ, Sollee D, Schauben JL, et al. Pediatric guanfacine exposures reported to the National Poison Data System, 2000–2016. Clin Toxicol. 2020;58(1):49–55.
  • Panther SG, Knotts AM, Odom-Maryon T, et al. Off-label prescribing trends for ADHD medications in very young children. J Pediatr Pharmacol Ther. 2017;22(6):423–429.
  • Black BT, Soden SE, Kearns GL, et al. Clinical and pharmacologic considerations for guanfacine use in very young children. J Child Adolesc Psychopharmacol. 2016;26(6):498–504.
  • McGrath JC, Klein-Schwartz W. Epidemiology and toxicity of pediatric guanfacine exposures. Ann Pharmacother. 2002;36(11):1698–1703.
  • Food and Drug Administration. Guanfacine extended-release (ER). Available from: www.fda.gov.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.